3.31.23 | Autoimmune The Need for Diversity in Autoimmune Disease Research Trials
While the United States has made progress to close the gaps that have resulted from the historical exclusion of women […]
3.22.23 | Autoimmune Diversity in Autoimmune Clinical Trials: Addressing Areas of Need and Opportunity
During this SWHR Instagram Live event, hear from experts about why clinical trial representation is critical for improving outcomes, where they see the greatest issues in clinical trial representation, and if federal proposals to rectify underrepresentation of certain populations could improve involvement.
2.10.23 | Policy The Role of Diversity in Science and NIH’s Recent Efforts to Create a Culture of Inclusion
Dr. Marie Bernard, NIH Chief Officer for Scientific Workforce Diversity spoke to SWHR Policy Advisory Council members about diversity’s impact on science, the NIH-Wide Strategic Plan for DEIA, COSWD’s recent efforts, and the NIH UNITE Initiative.
1.18.23 | Research and Clinical Trials Friends of ORWH Congressional Reception
The Friends of the Office of Research on Women’s Health invite you to a congressional reception in celebration of Women’s […]
12.15.22 | Health Equity SWHR Releases Women’s Health Dashboard
In an effort to highlight and address disparities in women’s health across the lifespan, SWHR launched the Women’s Health Dashboard, as a centralized platform explore the latest data on health conditions and diseases that have significant impacts on women’s health.
12.7.22 | Health Equity To Address Women’s Health Inequity, It Must First Be Measured
The Society for Women’s Health Research (SWHR) President and CEO Kathryn Schubert joined a group of health equity experts in […]
10.27.22 | Policy SWHR’s 2022 Health Care Value Assessment Principles
In 2019, SWHR conceived a set of principles to help ensure value frameworks and assessments reflected factors relevant to women […]
10.6.22 | Health Equity How a Public Health Crisis Created an Impetus for Change: The Robert Wood Johnson Foundation’s National Commission to Transform Public Health Data Systems
Published in Health Equity, this discussion transcript focuses on how the COVID-19 pandemic brought to light the serious and pervasive […]
8.25.22 | Research and Clinical Trials NASEM Report Calls for Improved Diversity in Research
The NASEM report on improving representation in clinical trials outlines the high cost of care and poor patient outcomes that are a consequence of not increasing diversity in research.
8.15.22 | Maternal Health SWHR Assumes Administration Responsibilities of the Coalition to Advance Maternal Therapeutics
SWHR will oversee the Coalition to Advance Maternal Therapeutics (CAMT), a coalition founded in 2014 to increase inclusion of pregnant and lactating populations in clinical research.
